Fast Market Research recommends "Amyotrophic Lateral Sclerosis - Analysis and Market Forecasts to 2019" from GlobalData, now available
Boston, MA -- (SBWIRE) -- 03/26/2013 -- GlobalData, the industry analysis specialist, has released its new report, "Amyotrophic Lateral Sclerosis - Analysis and Market Forecasts to 2019". The report is an essential source of information and analysis on the global Amyotrophic Lateral Sclerosis Therapeutics market. The report identifies the key trends shaping and driving the global Amyotrophic Lateral Sclerosis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Amyotrophic Lateral Sclerosis Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
View Full Report Details and Table of Contents
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Amyotrophic Lateral Sclerosis Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets.
- Pipeline candidates fall under major therapeutic classes. Analysis of the current and future competition in the seven key countries Amyotrophic Lateral Sclerosis Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Amyotrophic Lateral Sclerosis Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Amyotrophic Lateral Sclerosis Therapeutics market.
Reasons to Get This Report
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Amyotrophic Lateral Sclerosis Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Amyotrophic Lateral Sclerosis Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Companies Mentioned in this Report: Sanofi, Avicena, Biogen, Mitsubishi Tanabe Pharma
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Amyotrophic Lateral Sclerosis (ALS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Neurodegenerative Disease Market to 2017 - Patent Expiries of High Selling Drugs Such as Aricept, Namenda, Avonex, Rebif and Copaxone will Restrain Growth
- Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2012
- Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2012
- Amyotrophic Lateral Sclerosis Global Clinical Trials Review, Q1, 2011
- Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2011
- Multiple Sclerosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
- Endpoints - Clinical Trials in Orphan Diseases - Highest Number of Terminated Trials Focused on Mulitiple Myeloma
- Hyperparathyroidism - Analysis and Market Forecasts to 2019
- Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019